Turim 21 Investimentos’s ARK Genomic Revolution ETF ARKG Stock Holding History

Turim 21 Investimentos’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-496	Closed	-$16K	–	88
2022 Q2	$16K	Hold	496	–	–	0.01%	75
2022 Q1	$23K	Buy	496 +218	+78%	+$10.4K	0.01%	87
2021 Q4	$17K	Hold	278	–	–	0.01%	72
2021 Q3	$21K	Sell	278 -480	-63%	-$40.3K	0.01%	67
2021 Q2	$70K	Buy	758 +130	+21%	+$11.1K	0.02%	63
2021 Q1	$56K	Buy	+628	New	+$62.3K	0.03%	37

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Turim 21 Investimentos's ARKG Position: Q3 2022 in Review

Turim 21 Investimentos sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 496 shares — an estimated $16K sold.

Turim 21 Investimentos first reported a position in ARKG in Q1 2021 and held it in 6 quarters. The position peaked at $70K in Q2 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

Turim 21 Investimentos reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
Turim 21 Investimentos sold 496 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $16K.
Turim 21 Investimentos first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 6 quarters.
Turim 21 Investimentos's ARK Genomic Revolution ETF position peaked at $70K in Q2 2021.
311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Turim 21 Investimentos's 13F filing for Q3 2022, filed 14 Nov 2022.